WHWK

Whitehawk Therapeutics, Inc. Common Stock
WHWK

Overview Fund Activity

15 hedge funds and large institutions have $47.5M invested in Whitehawk Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
15
Holders Change
+14
Holders Change %
+1,400%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
1
OrbiMed
New York
$21.6M
2
AG
2
Artal Group
Luxembourg
$6.47M
3
SFM
3
Sphera Funds Management
Israel
$4.58M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$3.65M
5
TCM
5
Tekla Capital Management
Massachusetts
$3.18M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
O
1
OrbiMed
New York
$21.6M 5,193,946 +5,193,946 New
AG
2
Artal Group
Luxembourg
$6.47M 1,558,400 +1,558,400 New
SFM
3
Sphera Funds Management
Israel
$4.58M 1,103,554 +1,103,554 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$3.65M 879,100 +879,100 New
TCM
5
Tekla Capital Management
Massachusetts
$3.18M 765,000 +765,000 New
GPCM
6
Granite Point Capital Management
Massachusetts
$3.11M 750,000 +750,000 New
CH
7
CVI Holdings
Delaware
$1.87M 450,676 +450,676 New
NC
8
Nexthera Capital
New York
$1.24M 298,873 +298,873 New
Millennium Management
9
Millennium Management
New York
$934K 225,000 +225,000 New
NRS
10
Neville Rodie & Shaw
New York
$415K 100,000 – –
MCM
11
Moore Capital Management
New York
$415K 100,000 +100,000 New
HighTower Advisors
12
HighTower Advisors
Illinois
$52K 12,500 +12,500 New
TI
13
Truepoint Inc
Ohio
$42K 10,219 +10,219 New
AWP
14
Ascent Wealth Partners
New York
$41K 10,000 +10,000 New
TRCT
15
Tower Research Capital (TRC)
New York
$0 100 +100 New